A review of tickets was performed for reagent lot number 07124be00.The ticket search determined that there is normal complaint activity for the likely cause lot.A review of tracking and trending did not identify any trends for the complaint issue.Return testing was not completed as returns were not available.Retained reagent kits of lot number 07124be00 were tested in a sensitivity setup including two sensitivity panels and the positive control on two analyzers.All values met specifications and all results were in the typical range and no false nonreactive results were obtained.Additionally, two commercially available seroconversion panels were tested on one analyzer.The results were compared to architect anti-hcv test results provided by the panel manufacturer.The reagent detected the same bleeds as reactive with comparable s/co values for the seroconversion panels.A review of the manufacturing documentation did not identify any issues associated with the complaint issue.A review of labeling concluded that the issue is sufficiently addressed.Based on the investigation no systemic issue or deficiency of the architect anti-hcv reagent, lot number 07124be00 was identified.
|